75
5
2
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T14881 | CB1 antagonist 2 | AM4113 | Cannabinoid Receptor |
CB1 antagonist 2 (AM4113) is caimabinoid 1 (CB1) antagonist which inhibits CB1 in vivo with an IC50 of 25.5 nM. | |||
T8511 | TM38837 | Cannabinoid Receptor | |
TM38837 is an antagonist of cannabinoid receptor type 1 (CB1), with potential for the treatment of obesity and type 2 diabetes. | |||
T9466 | RTICBM-189 | Others | |
RTICBM-189 is a potent, brain-penetrant allosteric modulator of the cannabinoid type-1 (CB1) receptor with a pIC50 of 7.54 in Ca2+ mobilization assay. RTICBM-189 has pIC50s of 5.29 and 6.25 for hCB1 and mCB1, respectivel... | |||
T12306 | OMDM-5 | Cannabinoid Receptor , Endogenous Metabolite , TRP/TRPV Channel | |
OMDM-5 is a selective anandamide cellular uptake (ACU)inhibitor(Ki of 4.8 μM). | |||
T2264 | AM281 | Cannabinoid Receptor | |
AM 281, a cannabinoid antagonist, reduces neurologic dysfunction and mortality rate after cecal ligation and puncture in rats. | |||
T5996 | CB1-IN-1 | DBPR211 | Cannabinoid Receptor |
CB1-IN-1 (DBPR211) is a peripherally restricted CB1R antagonist, for CB1R and CB2R with Ki of 0.3 nM and 21 nM,respectively. | |||
T12302 | OMDM-1 | (Z)-N-[(2S)-1-hydroxy-3-(4-hydroxyphenyl)propan-2-yl]octadec-9-enamide | Endogenous Metabolite |
OMDM-1 ((Z)-N-[(2S)-1-hydroxy-3-(4-hydroxyphenyl)propan-2-yl]octadec-9-enamide) is a selective and metabolically stable anandamide cellular uptake (ACU)inhibitor with a Ki of 2.4 μM. | |||
T29930 | AM-1235 | AM 1235,AM1235 | Cannabinoid Receptor |
AM-1235 is a potent and selective cannabinoid receptor CB1 agonist. | |||
T22114 | NESS 0327 | Cannabinoid Receptor | |
NESS 0327 is a high selectivity antagonist of the cannabinoid CB1 receptor. NESS 0327 is more than 60,000-fold selective for the CB1 receptor. | |||
T2635 | Org 27569 | Cannabinoid Receptor | |
Org 27569, an allosteric modulator of cannabinoid CB1 receptor, can induce a CB1 receptor state that is characterized by decreased inverse agonist affinity and enhanced agonist affinity. | |||
T6527 | GW842166X | Cannabinoid Receptor | |
GW842166X is a potent and highly selective agonist of cannabinoid receptor CB2 receptor with EC50 of 63 nM, shows no significant activity at CB1 receptor. Phase 2. | |||
T6755 | AM1241 | Cannabinoid Receptor | |
AM-1241 is a selective cannabinoid CB2 receptor agonist with Ki of 3.4 nM, exhibits 82-fold selectivity over CB1 receptor. | |||
T1519 | Rimonabant hydrochloride | SR 151716A,SR 141716A | Cannabinoid Receptor , Antibacterial |
Rimonabant hydrochloride (SR 141716A) is a cannabinoid receptor antagonist, binding selectively to central cannabinoid receptors (CB1) with high affinity. | |||
T79909 | AEF0117 | Cannabinoid Receptor | |
AEF0117, a signaling-specific inhibitor of cannabinoid receptor 1 (CB1-SSi), inhibits cannabinoid self-administration and behavioral disorders associated with THC, and can be used to study cannabis withdrawal. | |||
T7375 | A-836339 | Cannabinoid Receptor | |
A-836339 acts as a potent cannabinoid receptor full agonist which has a higher affinity for the peripheral CB2 receptor (Ki = 0.64 nM) over the central CB1 receptor (Ki = 270 nM). It displays analgesic, anti-inflammatory... | |||
T41350 | 6-Bromopravadoline | WIN 54461 | Cannabinoid Receptor |
6-Bromopravadoline (WIN 54461) (WIN 54461) is an antagonist of CB1. 6-Bromopravadoline acts as an inhibitor of the binding of [3H]Win 55212-2 (IC 50 =515 nM) reflective of cannabinoid receptor binding [1] [2]. | |||
T7316 | LY2828360 | Cannabinoid Receptor | |
LY2828360 is a cannabinoid (CB) receptor 2 agonist (Ki = 40.3 nM). It selectively activates CB2 over CB1 in a GTPγS binding assay (EC50s = 20.1 and >100,000 nM, respectively). | |||
T1519L | Rimonabant | SR141716 | Cannabinoid Receptor , Antibacterial , Acyltransferase |
Rimonabant (SR141716) is an inverse agonist for the cannabinoid receptor CB1. It is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. Its main avenue of effect is a reduction in appetite. Rimonabant... | |||
T36520 | COR659 | Cannabinoid Receptor , GABA Receptor | |
COR659 is a GABAB positive allosteric modulator (PAM) . COR659 suppresses alcohol and chocolate self-administration in rats[1]. COR659 apparently exerts its effects via a composite mechanism, including positive allosteri... | |||
T3530 | Otenabant | CP-945598 | Cannabinoid Receptor |
Otenabant (CP-945598) has been investigated for the treatment of Obesity. | |||
T41231 | GP 1a | Cannabinoid Receptor , PERK , Arrestin | |
GP 1a is a potent agonist of cannabinoid receptor 2 (CB2) (EC50=7.1), as shown in cAMP, GTPγS and β-arrestin recruitment assays. GP 1a is approximately 30-fold more selective for CB2 receptors than CB1 receptors and incr... | |||
T27803 | LBP-1 | LBP1 | |
LBP-1 is a cannabinoid receptor type 1 (CB1) agonist. | |||
T28657 | SAD-448 | ||
SAD-448 is a cannabinoid receptor type 1 (CB1) agonist. SAD-448 controls spasticity via action on the peripheral nerve CB1 receptor. | |||
T29929 | AM-1220 | AM 1220,AM1220 | |
AM-1220 is a potent and moderately selective agonist of the cannabinoid receptor CB1. | |||
T13081 | Taranabant racemate | MK-0364 racemate | Cannabinoid Receptor |
Taranabant racemate is an antagonist and/or inverse agonist of the Cannabinoid-1 (CB1) receptor. | |||
T28006 | MDMB-CHMINACA | (S)-MDMB-CHMINACA | |
MDMB-CHMINACA, an indazole-based synthetic cannabinoid, acts as a potent agonist of the CB1 receptor. | |||
T32336 | JWH-149 | ||
JWH 149, a synthetic cannabinoid (CB), can potently bind both the central CB1 receptor (Ki = 5.0 nM) and the peripheral CB2 receptor (Ki = 0.73 nM). | |||
T24231 | JWH-198 | JWH 198 | |
JWH 198 is a synthetic cannabinoid. It binds the central CB1 receptor with high affinity (Ki: 10 nM). | |||
T68515 | AZD-1175 | ||
AZD-1175 is a cannabinoid receptor CB1 antagonist and highly lipophilic compound for the treatment of type 2 diabetes and obesity. | |||
T32341 | JWH-251 | ||
JWH 251, a cannabimimetic indole, has a high affinity tothe central cannabinoid (CB1) receptor (Ki = 29 nM) and a comparatively modest affinity for the peripheral cannabinoid (CB2) receptor (Ki = 146 nM). JWH 251 can st... | |||
T24230 | JWH-193 | JWH 193 | |
JWH 193 is a synthetic cannabinoid (CB) that binds the central CB1 receptor with high affinity (Ki: 6 nM). | |||
T25874 | NMP-7 | NMP7,NMP 7 | |
NMP-7 is a non-selective CB1 and CB2 cannabinoid receptor agonist that works by blocking T-type calcium channels. | |||
T14504 | BAY 38-7271 | Cannabinoid Receptor | |
BAY 38-7271 has strong neuroprotective properties.[1] BAY 38-7271 is selective and highly potent and cannabinoid CB1/CB2 receptor agonist. With Kis of 1.85 nM and 5.96 nM for recombinant human CB1 receptor and CB2 recept... | |||
T61105 | GAT228 | ||
GAT228, an allosteric ligand for the cannabinoid receptor 1 (CB1), functions as the enantiomer of GAT211 [1]. | |||
T17027 | Tedalinab | GRC-10693 | Cannabinoid Receptor |
Tedalinab is an effective and selective cannabinoid receptor 2 agonist. Tedalinab has the potential for neuropathic pain and osteoarthritis treatment. Tedalinab has >4700-fold functional selectivity for CB2 over CB1. | |||
T68500 | AZD-2207 | ||
AZD-2207 is a cannabinoid receptor CB1 antagonist and highly lipophilic compound for the treatment of type 2 diabetes mellitus and obesity. | |||
T30103 | APP-CHMINACA | PX-3,PX3 | |
APP-CHMINACA is a synthetic cannabinoid (CB) featuring a 1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (CHMINACA) base. It displays a 10-fold greater affinity for the central CB1 receptor than that of JWH 018. | |||
T79137 | Monlunabant | (S)-MRI-1891 | Cannabinoid Receptor |
Monlunabant ((S)-MRI-1891), a solid dispersion compound, functions as an inhibitor of the cannabinoid CB1 receptor [1]. | |||
T24939 | Virodhamine trifluoroacetate | Virodhamine-trifluoroacetate,Virodhamine trifluoroacetate salt | |
Virodhamine trifluoroacetate is an antagonist of endogenous cannabinoid receptor mixed that acts by being a full agonist at GPR55 and CB2 and partial antagonist at CB1. | |||
T24218 | JTE 7-31 | ||
JTE 7-31 is a selective agonist of the cannabinoid receptor. It is a reasonably highly selective CB2 agonist (Ki: 0.088 nM at CB2 vs 11 nM at CB1). | |||
T32334 | JWH-098 | ||
JWH 098, a potent synthetic cannabinoid (CB), can activate the CB1 receptor with a Ki value of 4.5 nM and the CB2 receptor with a Ki value of 1.88 nM. Its effects in cells and animals are still on study. | |||
T32582 | LASSBio-881 | LASSBio881,LASSBio 881 | |
LASSBio-881 is a non-selective partial agonist of the CB1 and CB2 cannabinoid receptors, as well as an antagonist of the TRPV1 receptor. | |||
T32338 | JWH-182 | JWH182 | |
JWH 182, a potent synthetic cannabinoid (CB) can activate the central CB1 receptor and the peripheral CB2 receptor with a Ki value of 0.65 nM and 1.1 nM, respectively. Its effects in cells and animals have not evaluated. | |||
T39410 | Zevaquenabant | (S)-MRI-1867 | |
Zevaquenabant ((S)-MRI-1867), a dual cannabinoid CB1 receptor and inducible NOS (iNOS) antagonist, is orally bioavailable and peripherally restricted. It effectively mitigates obesity-induced chronic kidney disease (CKD)... | |||
T32331 | JWH 072 | JWH072,JWH-072 | |
JWH 072 , known as synthetic cannabinoid (CB), displays a higher affinity to the peripheral CB2 receptor (Ki = 170 nM) than the central CB1 receptor (Ki = 1,050 nM). Its physiological and toxicological properties are sti... | |||
T13080L | Taranabant | MK-0364 | Cannabinoid Receptor |
Taranabant (MK-0364) is a selective and potent cannabinoid 1 (CB1) receptor inverse agonist used in the study of obesity and nicotine dependence. | |||
T38049 | Glycerophospho-N-Palmitoyl Ethanolamine | ||
N-Acylated ethanolamines (NAE) are naturally-occurring lipids that have diverse bioactivities. For example, arachidonoyl ethanolamide (AEA) is an endogenous neurotransmitter that evokes cellular responses by activating t... | |||
T38199 | (±)-WIN 55,212 (mesylate) | ||
(±)-WIN 55,212-2 is a potent aminoalkylindole cannabinoid (CB) receptor agonist with a Ki value of 62.3 and 3.3 nM for human recombinant central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors, respectively.... | |||
T30903 | CHM-081 | CHM 081 | |
JWH 081, a cannabimimetic aminoalkylindole, has a high-affinity to the central cannabinoid (CB1) receptor (Ki =1.2 nM) and ten-fold reduced affinity to the peripheral cannabinoid (CB2) receptor (Ki = 12.4 nM). JWH 081-N-... | |||
T78674 | Isopropyl dodec-11-enylfluorophosphonate | IDEFP | FAAH |
Isopropyl dodec-11-enylfluorophosphonate (IDEFP) is an organophosphorus ester functioning as a central cannabinoid receptor (CB1) antagonist and exhibits equipotent inhibition of fatty acid amide hydrolase (FAAH), with b... |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2S0271 | Voacamine | Voacanginine | Cannabinoid Receptor , P-gp |
Voacamine (Voacanginine) is an indole alkaloid. Voacamine exhibits potent cannabinoid CB1 receptor antagonistic activity. Voacamine also inhibits P-glycoprotein (P-gp) action in multidrug-resistant tumor cells.Voacangini... | |||
TC0019 | Pregnenolone acetate | 3β-Hydroxy-5-pregnen-20-one acetate | Cannabinoid Receptor , Endogenous Metabolite |
Pregnenolone acetate is a powerful neurosteroid, the main precursor of various steroid hormones including steroid ketones. It acts as a signaling-specific inhibitor of cannabinoid CB1 receptor, inhibits the effects of te... | |||
TN5131 | Tetrahydrocannabivarin | THCV,delta9-Tetrahydrocannabivarin,CRM,Tetrahydrocannavarin | Cannabinoid Receptor |
Tetrahydrocannabivarin (CRM) is a neutral cannabis receptor subtype (CB1) receptor antagonist, it can increases neural responding to rewarding and aversive stimuli, this effect profile suggests therapeutic activity in ob... | |||
T11834 | Leelamine hydrochloride | Others | |
Leelamine hydrochloride, a tricyclic diterpene extracted from pine tree bark, inhibits the transcriptional activity of the androgen receptor, known to regulate fatty acid synthesis [2,3]. This compound acts as a cannabin... | |||
T16574 | Pregnenolone monosulfate sodium salt | 3β-Hydroxy-5-pregnen-20-one monosulfate sodium salt | Others |
Pregnenolone monosulfate sodium salt is a powerful neurosteroid, the main precursor of various steroid hormones including steroid ketones. Pregnenolone monosulfate sodium salt can protect the brain from cannabis intoxica... |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-03256 | CNR1 Protein, Rat, Recombinant (His) | Rat | in vitro E. coli expression system |
G-protein coupled receptor for cannabinoids, including endocannabinoids (eCBs), such as N-arachidonoylethanolamide (also called anandamide or AEA) and 2-arachidonoylglycerol (2-AG). Mediates many cannabinoid-induced effe... | |||
TMPH-01035 | CNR1 Protein-VLP, Human, Recombinant (His) | Human | HEK293 |
G-protein coupled receptor for endogenous cannabinoids (eCBs), including N-arachidonoylethanolamide (also called anandamide or AEA) and 2-arachidonoylglycerol (2-AG), as well as phytocannabinoids, such as delta(9)-tetrah... |